La solucin por supuesto no es reducir nuestra microbiota intestinal, la respuesta es NO DAR L-CARNITINA A LAS BACTERIAS DEL INTESTINO QUE LA UTILIZAN COMO FUENTE ALIMENTICIA
The trial randomised adults with obesity who have achieved 5% WL by the end of the 12-week lead-in period (mean WL at the lead-in period was 6.9%) to placebo or tirzepatide
It could be a sign of low B12 levels
Another weight-loss drug, Mounjaro, became available privately in February 2024 and via the NHS in June
The appetite-suppressing and GI-motility-altering effects of GLP-1 receptor agonists can reduce salivary flow in some patients, potentially exacerbating Sjogren's oral symptoms
Najman, S., et al., Chemopreventive potential of alpha lipoic acid in the treatment of colon and cervix cancer cell lines